Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Euzebiusz Jamrozik

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
BMJ Global Health|May 26, 2022
The unintended consequences of COVID-19 vaccine policy: why mandates, passports and restrictions may cause more harm than goodKevin Bardosh, Alex de Figueiredo, Rachel Gur-Arie, et al.
BMJ Open|February 7, 2025
An analysis of controlled human infection studies registered on ClinicalTrials.govDanny Toomey, Jupiter Adams-Phipps, James Wilkinson, et al.
Plos Neglected Tropical Diseases|February 5, 2025
Perceptions of a Buruli ulcer controlled human infection model: How, who, and why?Stephen Muhi, Simone Schmidt, Julia L Marshall, et al.
Vaccine|December 20, 2020
Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working GroupEuzebiusz Jamrozik, Katherine Littler, Susan Bull, et al.
Wellcome Open Research|October 10, 2024
A human model of Buruli ulcer: Provisional protocol for a <i>Mycobacterium ulcerans</i> controlled human infection studyStephen Muhi, Julia L Marshall, Daniel P O'Brien, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 19, 2025
Incorporating ethics into infectious disease clinical practice guidelinesElda Righi, Dafna Yahav, Asma Nasim, et al.
JAMA Network Open|July 10, 2025
Incorporating Ethics in Clinical Guidelines in Infectious Diseases: A Scoping ReviewDafna Yahav, Asma Nasim, Neta Shirin, et al.
The Lancet. Microbe|January 26, 2026
Controlled human infection with Mycobacterium tuberculosis: practical considerations for clinical trialsChetan Seshadri, JoAnne L Flynn, Pauline Maiello, et al.
Therapie|December 17, 2023
Controlled human infection trials: Legitimacy and conditions of implementation in FranceAnne-Laure Morin, Emmanuelle Blanc, Armelle Phalipon, et al.
Vaccine|February 25, 2022
Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshopEloise Williams, Kathrine Craig, Christopher Chiu, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
BMJ Global Health|May 26, 2022
The unintended consequences of COVID-19 vaccine policy: why mandates, passports and restrictions may cause more harm than goodKevin Bardosh, Alex de Figueiredo, Rachel Gur-Arie, et al.
BMJ Open|February 7, 2025
An analysis of controlled human infection studies registered on ClinicalTrials.govDanny Toomey, Jupiter Adams-Phipps, James Wilkinson, et al.
Plos Neglected Tropical Diseases|February 5, 2025
Perceptions of a Buruli ulcer controlled human infection model: How, who, and why?Stephen Muhi, Simone Schmidt, Julia L Marshall, et al.
Vaccine|December 20, 2020
Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working GroupEuzebiusz Jamrozik, Katherine Littler, Susan Bull, et al.
Wellcome Open Research|October 10, 2024
A human model of Buruli ulcer: Provisional protocol for a <i>Mycobacterium ulcerans</i> controlled human infection studyStephen Muhi, Julia L Marshall, Daniel P O'Brien, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 19, 2025
Incorporating ethics into infectious disease clinical practice guidelinesElda Righi, Dafna Yahav, Asma Nasim, et al.
JAMA Network Open|July 10, 2025
Incorporating Ethics in Clinical Guidelines in Infectious Diseases: A Scoping ReviewDafna Yahav, Asma Nasim, Neta Shirin, et al.
The Lancet. Microbe|January 26, 2026
Controlled human infection with Mycobacterium tuberculosis: practical considerations for clinical trialsChetan Seshadri, JoAnne L Flynn, Pauline Maiello, et al.
Therapie|December 17, 2023
Controlled human infection trials: Legitimacy and conditions of implementation in FranceAnne-Laure Morin, Emmanuelle Blanc, Armelle Phalipon, et al.
Vaccine|February 25, 2022
Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshopEloise Williams, Kathrine Craig, Christopher Chiu, et al.
Pageof 7